University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 29 of 35
Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut
NCT00884793
Internet Stop Smoking Study - Phase VI
NCT00721786
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
NCT00735072
Intervention for (Those) Recently Informed of Seropositive Status (IRISS)
NCT00720733
Motor Evoked Potentials and SedLine
NCT00805844
Omega-3 Fatty Acids for Autism Treatment
NCT00786799
Evaluating Parental Influences on Obesity Among Mexican American Children
NCT00542672
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
NCT00734682
Statins and Endothelial Function in Patients With Coarctation of the Aorta
NCT00767572
Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers
NCT00731315
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
NCT00632827
Reducing Distress and Improving Self-Care in Diabetes
NCT00714441
Vest Prevention of Early Sudden Death Trial and VEST Registry
NCT01446965
Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
NCT00728117
Alzheimer's Family Research
NCT00878059
Effects of Vitamin D on Lipids
NCT00723385
Hydrogel Patch for the Treatment of Eczema
NCT00924508
Deep Brain Stimulation in Patients With Dystonia
NCT00773604
Pain Medicine for Wound Care Procedures
NCT00701909
Pharmacogenetics of Bupropion Metabolism
NCT00791869
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
NCT00655239
Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream
NCT00622440
An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV
NCT00611429
PTH & Ibandronate Combination Study (PICS)
NCT00683163
Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter
NCT00686231
Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer
NCT00678015
Impact of Extensive Consultation on Career Development Grant Outcomes
NCT00662402
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
NCT00672932
Botox for Cervical Dystonia Following EMG Mapping
NCT00773253
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
NCT00877591
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
NCT00662545
Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric Disorders
NCT00618943
Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery
NCT00644280
Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)
NCT00670956
Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium
NCT00655070
Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension
NCT00675051
Treatment of Acute Hepatitis C Virus in HIV Co-Infection
NCT00845676
Weight-Bearing Magnetic Resonance Imaging (MRI) for Analysis of Knee Osteoarthritis (OA)
NCT00665548
Influence of MMP on Brain AVM Hemorrhage
NCT00783523
Bad Breath Response to Tongue Scraper and Rinses
NCT00867035
Web-Based Active Balance Childhood Study in Chinese-American
NCT00961246
Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy
NCT00807820
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
NCT00626158
Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers
NCT00634218
Raltegravir Intensification in HIV-infected Patients
NCT00631449
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
NCT00618449
Alpha Lipoic Acid and Insulin Resistance
NCT00845156
Dyspnea in Patients With Pulmonary Fibrosis
NCT00611182
Mechanisms of Acute Asthma Exacerbations Through Molecular Analysis of Airway Secretions and Tissues
NCT00603629
Craving and Lifestyle Management Through Mindfulness Pilot Study
NCT00643344
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.